Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SZ-A vs Metformin in Obese Pediatric Type 2 Diabetes Mellitus
ChiCTR2600125742Phase 3Recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ramulus mori alkaloids in type 2 diabetes mellitus (T2DM) and obesity (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: Hemoglobin A1c. Started May 2026; status: recruiting.
02
Drugs
ramulus mori alkaloids
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on ChiCTR2600125742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125742.